Mönig Stefan Paul, Chevallay Mickael, Niclauss Nadja, Toso Christian, Frossard Jean-Louis, Koessler Thibaud, Jung Minoa Karin
Service de chirurgie viscérale, HUG, 1211 Genève 14.
Service de gastroentérologie et d'hépatologie, HUG, 1211 Genève 14.
Rev Med Suisse. 2020 Jul 1;16(699):1292-1299.
Esophageal cancer remains an oncological burden with a low survival rate. Multidisciplinary management is essential to offer an adjusted treatment to the patient general condition and the tumor stage. New minimally invasive surgical treatments help to reduce the surgical trauma and improve post-operative patient recovery. Oncological treatments have also evolved and definitive treatment by radio-chemotherapy can be proposed in specific cases.
食管癌仍然是一种肿瘤负担，生存率较低。多学科管理对于根据患者的总体状况和肿瘤分期提供个体化治疗至关重要。新的微创外科治疗有助于减少手术创伤并促进患者术后恢复。肿瘤治疗也有所发展，在特定情况下可采用放化疗进行确定性治疗。
